Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Date:4/30/2008

----------------

Cash provided by financing

activities - 12,068,172 96,253,751

-------------------------------------------------------------------------

Net increase in cash and cash

equivalents during the period 611,610 7,833,768 7,326,706

Cash and cash equivalents,

beginning of the period 6,715,096 3,491,511 -

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Cash and cash equivalents,

end of the period 7,326,706 11,325,279 7,326,706

-------------------------------------------------------------------------

-------------------------------------------------------------------------

See accompanying notes

Oncolytics Biotech Inc.

NOTES TO FINANCIAL STATEMENTS

March 31, 2008 (unaudited)

1. INCORPORATION AND NATURE OF OPERATIONS

Oncolytics Biotech Inc. (the "Company" or "Oncolytics") was incorporated

on April 2, 1998 under the Business Corporations Act (Alberta) as 779738

Alberta Ltd. On April 8, 1998, the Company changed its name to Oncolytics

Biotech Inc.

The Company is a development stage biopharmaceutical company that focuses

on the discovery and development of pharmaceutical products for the

treatment of cancers that have not been successfully treated with

conventional therapeutics. The product being developed by the Company may

represent a novel treatment for Ras mediated cancers which can be used as

an alternative to existing cytotoxic or cytostatic therapies, as an

adjuvant therapy to conventional chemotherapy, radiation therapy, or

surgical resections, or to treat certain cellular proliferative disorders

for which no current thera
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Capital, a firm specializing in acquiring and managing food ... the Slim-Fast brand from Unilever. Unilever will retain a ... were not disclosed. Slim-Fast is a branded ... shakes, powders, bars and snacks to retail customers throughout ... United Kingdom and Ireland.  The ...
(Date:7/10/2014)... in the fight against terrorism with the creation of ... with the use of light and special glass fibres. ... B: Chemical , the researchers describe a novel optical ... low as 6.3 ppm (parts per million). It requires ... "Traditionally explosives detection has involved looking for metals that ...
(Date:7/10/2014)... RICHLAND, Wash. The lithium-ion batteries that power our ... run longer on a single charge with the help ... the porous material to replace the graphite traditionally used ... more than 10 times the energy storage capacity of ... lithium-ion battery electrode was published today in Nature ...
(Date:1/15/2014)... approach akin to assembling a club sandwich at ... (NIST) researchers have succeeded in crafting a uniform, ... of foam commonly used in upholstered furniture and ... nanotube-coated polyurethane foam was reduced 35 percent compared ...
Breaking Biology Technology:Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... STRONG BACKGROUND IN BIOTECHNOLOGY, SHANGHAI, China, Aug. ... Bulletin Board: SOBM) is pleased to,announce that it ... financial,advisor to evaluate strategic alternatives to maximize shareholder ... the results obtained from the work,undertaken to date ...
... Nathan,s Famous Hot Dog Eating,contest may have Joey ... Del Rosario "champ.", The senior human resources associate ... earlier this month when she won Brown &,Toland,s inaugural ... American Heart Association., Brown & Toland recognizes the ...
... /PRNewswire-FirstCall/,-- Oridion Systems Ltd. (SWX: ORIDN) today ... leading global medical device and service company.,With ... technology in its new, compact and ultra-lightweight ... the importance of monitoring CO2, has,decided to ...
Cached Biology Technology:Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value 2Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value 3Bacon Eating Contest Raises Money for American Heart Association 2Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 2Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 3Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare 4
(Date:7/11/2014)... July 3, 2014, Shenzhen, China Researchers from Salk ... for the first time evaluated the safety and ... and successfully developed a new method, TALEN-HDAdV, which ... pluripotent stem cell (hiPSC). This study published online ... important theoretical foundation for stem cell-based gene therapy. ...
(Date:7/11/2014)... team of researchers, including scientists from the Max Planck ... reported a major step in understanding photosynthesis, the process ... the oxygen in its atmosphere and which is therefore ... , The researchers report the first direct visualization ... the step in which a specific protein complex, photosystem ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2A first direct glimpse of photosynthesis in action 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... potential as a large-scale, emission-free energy source, bat and ... fatalities annually. Migratory bats, such as the hoary bat, ... as they fly their routes in the forested ridges ... the immediate area, but is also detrimental to ecosystem ...
... 2007 and based in Toronto, ArcticDx has developed a ... specifically designed to determine one,s inherited risk for age-related ... blindness in the developed world, affecting over 10% of ... undertake studies in support of a planned filing for ...
... 2010 issue of " Environmental Pollution " details ... rabbit,s food resulted in the abiotic (non-biological) transformation ... reducing the levels of these estrogen hormones by ... research has practical implications since it could point ...
Cached Biology News:Slight change in wind turbine speed significantly reduces bat mortality 2OGI invests in personalized medicine for age-related macular degeneration 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 3
lid holder -see Blotters (Semi-Dry) for more info...
... QPlate is the consumable ... 16 contains 16 individually controlled ... contains a sophisticated liquid flow ... fast and precise solution and ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... bring you ease of use and rapid solutions to meet your laboratory's requirements for data management ... ... ... CLARA® is the standard software for Staccato Systems and ...
Biology Products: